ID   KPCD1_RAT               Reviewed;         918 AA.
AC   Q9WTQ1;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Serine/threonine-protein kinase D1;
DE            EC=2.7.11.13;
DE   AltName: Full=Protein kinase C mu type;
DE   AltName: Full=Protein kinase D;
DE   AltName: Full=nPKC-D1;
DE   AltName: Full=nPKC-mu;
GN   Name=Prkd1; Synonyms=Pkcm, Pkd, Prkcm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 718-864.
RC   STRAIN=Wistar; TISSUE=Brain;
RA   Minami H., Owada Y., Kondo H.;
RT   "Rat PKC mu mRNA partial cds.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION IN GOLGI REGULATION.
RX   PubMed=10412981; DOI=10.1016/s0092-8674(00)80606-6;
RA   Jamora C., Yamanouye N., Van Lint J., Laudenslager J., Vandenheede J.R.,
RA   Faulkner D.J., Malhotra V.;
RT   "Gbetagamma-mediated regulation of Golgi organization is through the direct
RT   activation of protein kinase D.";
RL   Cell 98:59-68(1999).
RN   [4]
RP   FUNCTION IN CARDIOMYOCYTE.
RX   PubMed=15514163; DOI=10.1161/01.res.0000149299.34793.3c;
RA   Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M.,
RA   Avkiran M.;
RT   "Protein kinase D is a novel mediator of cardiac troponin I phosphorylation
RT   and regulates myofilament function.";
RL   Circ. Res. 95:1091-1099(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-744; SER-748 AND SER-916.
RX   PubMed=15145937; DOI=10.1074/jbc.m404170200;
RA   Wang Y., Schattenberg J.M., Rigoli R.M., Storz P., Czaja M.J.;
RT   "Hepatocyte resistance to oxidative stress is dependent on protein kinase
RT   C-mediated down-regulation of c-Jun/AP-1.";
RL   J. Biol. Chem. 279:31089-31097(2004).
RN   [6]
RP   FUNCTION IN CARDIAC HYPERTROPHY.
RX   PubMed=15367659; DOI=10.1128/mcb.24.19.8374-8385.2004;
RA   Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N.,
RA   McKinsey T.A.;
RT   "Protein kinases C and D mediate agonist-dependent cardiac hypertrophy
RT   through nuclear export of histone deacetylase 5.";
RL   Mol. Cell. Biol. 24:8374-8385(2004).
RN   [7]
RP   FUNCTION IN NEURONAL POLARITY.
RX   PubMed=18784310; DOI=10.1523/jneurosci.1879-08.2008;
RA   Bisbal M., Conde C., Donoso M., Bollati F., Sesma J., Quiroga S.,
RA   Diaz Anel A., Malhotra V., Marzolo M.P., Caceres A.;
RT   "Protein kinase d regulates trafficking of dendritic membrane proteins in
RT   developing neurons.";
RL   J. Neurosci. 28:9297-9308(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-206, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase that converts transient
CC       diacylglycerol (DAG) signals into prolonged physiological effects
CC       downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and
CC       Ras signaling, Golgi membrane integrity and trafficking, cell survival
CC       through NF-kappa-B activation, cell migration, cell differentiation by
CC       mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2)
CC       signaling, and plays a role in cardiac hypertrophy, VEGFA-induced
CC       angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated
CC       inflammatory response (PubMed:10412981, PubMed:15367659,
CC       PubMed:15514163). Phosphorylates the epidermal growth factor receptor
CC       (EGFR) on dual threonine residues, which leads to the suppression of
CC       epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and
CC       subsequent JUN phosphorylation. Phosphorylates RIN1, inducing RIN1
CC       binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased
CC       competition with RAF1 for binding to GTP-bound form of Ras proteins
CC       (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein
CC       beta/gamma-subunit complex to maintain the structural integrity of the
CC       Golgi membranes, and is required for protein transport along the
CC       secretory pathway. In the trans-Golgi network (TGN), regulates the
CC       fission of transport vesicles that are on their way to the plasma
CC       membrane. May act by activating the lipid kinase phosphatidylinositol
CC       4-kinase beta (PI4KB) at the TGN for the local synthesis of
CC       phosphorylated inositol lipids, which induces a sequential production
CC       of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for
CC       membrane fission and generation of specific transport carriers to the
CC       cell surface. Under oxidative stress, is phosphorylated at Tyr-469 via
CC       SRC-ABL1 and contributes to cell survival by activating IKK complex and
CC       subsequent nuclear translocation and activation of NFKB1. Involved in
CC       cell migration by regulating integrin alpha-5/beta-3 recycling and
CC       promoting its recruitment in newly forming focal adhesion. In
CC       osteoblast differentiation, mediates the bone morphogenetic protein 2
CC       (BMP2)-induced nuclear export of HDAC7, which results in the inhibition
CC       of HDAC7 transcriptional repression of RUNX2. In neurons, plays an
CC       important role in neuronal polarity by regulating the biogenesis of
CC       TGN-derived dendritic vesicles, and is involved in the maintenance of
CC       dendritic arborization and Golgi structure in hippocampal cells
CC       (PubMed:18784310). May potentiate mitogenesis induced by the
CC       neuropeptide bombesin or vasopressin by mediating an increase in the
CC       duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of
CC       immediate-early gene products including FOS that stimulate cell cycle
CC       progression. Plays an important role in the proliferative response
CC       induced by low calcium in keratinocytes, through sustained activation
CC       of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a
CC       role in cardiac hypertrophy by phosphorylating HDAC5, which in turn
CC       triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A
CC       transcriptional activation and induction of downstream target genes
CC       that promote myocyte hypertrophy and pathological cardiac remodeling
CC       (PubMed:15367659). Mediates cardiac troponin I (TNNI3) phosphorylation
CC       at the PKA sites, which results in reduced myofilament calcium
CC       sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-
CC       HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-
CC       induced specific subset of gene expression, cell migration, and tube
CC       formation. In response to VEGFA, is necessary and required for HDAC7
CC       phosphorylation which induces HDAC7 nuclear export and endothelial cell
CC       proliferation and migration. During apoptosis induced by cytarabine and
CC       other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378,
CC       resulting in activation of its kinase function and increased
CC       sensitivity of cells to the cytotoxic effects of genotoxic agents. In
CC       epithelial cells, is required for transducing flagellin-stimulated
CC       inflammatory responses by binding and phosphorylating TLR5, which
CC       contributes to MAPK14/p38 activation and production of inflammatory
CC       cytokines. Acts as an activator of NLRP3 inflammasome assembly by
CC       mediating phosphorylation of NLRP3 (By similarity). May play a role in
CC       inflammatory response by mediating activation of NF-kappa-B. May be
CC       involved in pain transmission by directly modulating TRPV1 receptor.
CC       Plays a role in activated KRAS-mediated stabilization of ZNF304 in
CC       colorectal cancer (CRC) cells (By similarity). Regulates nuclear
CC       translocation of transcription factor TFEB in macrophages upon live
CC       S.enterica infection (By similarity). {ECO:0000250|UniProtKB:Q15139,
CC       ECO:0000250|UniProtKB:Q62101, ECO:0000269|PubMed:10412981,
CC       ECO:0000269|PubMed:15367659, ECO:0000269|PubMed:15514163,
CC       ECO:0000269|PubMed:18784310}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305};
CC   -!- ACTIVITY REGULATION: Activated by DAG and phorbol esters. Phorbol-
CC       ester/DAG-type domain 1 binds DAG with high affinity and appears to
CC       play the dominant role in mediating translocation to the cell membrane
CC       and trans-Golgi network. Phorbol-ester/DAG-type domain 2 binds phorbol
CC       ester with higher affinity. Autophosphorylation of Ser-748 and
CC       phosphorylation of Ser-744 by PKC relieves auto-inhibition by the PH
CC       domain. Phosphorylation on Tyr-469 by the SRC-ABL1 pathway in response
CC       to oxidative stress, is also required for activation. Activated by
CC       DAPK1 under oxidative stress (By similarity).
CC       {ECO:0000250|UniProtKB:Q15139}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with ADAP1/CENTA1. Interacts with
CC       MAPK13. Interacts with DAPK1 in an oxidative stress-regulated manner.
CC       Interacts with USP28; the interaction induces phosphorylation of USP28
CC       and activated KRAS-mediated stabilization of ZNF304 (By similarity).
CC       Interacts with AKAP13 (via C-terminal domain) (By similarity).
CC       {ECO:0000250|UniProtKB:Q15139, ECO:0000250|UniProtKB:Q62101}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q15139}. Cell
CC       membrane {ECO:0000250|UniProtKB:Q15139}. Golgi apparatus, trans-Golgi
CC       network {ECO:0000250|UniProtKB:Q62101}. Note=Translocation to the cell
CC       membrane is required for kinase activation.
CC       {ECO:0000250|UniProtKB:Q15139}.
CC   -!- PTM: Phosphorylated at Ser-403 and Ser-407 by MAPK13 during regulation
CC       of insulin secretion in pancreatic beta cells. Phosphorylated by DAPK1.
CC       Phosphorylated at Tyr-93 and by ABL at Tyr-469, which primes the kinase
CC       in response to oxidative stress, and promotes a second step activating
CC       phosphorylation at Ser-744/Ser-748 by PKRD. Phosphorylated on Ser-916
CC       upon S.enterica infection in macrophages.
CC       {ECO:0000250|UniProtKB:Q15139, ECO:0000250|UniProtKB:Q62101}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. PKD subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03048549; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03048623; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03048825; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03049215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03049278; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03050321; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03052344; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB020616; BAA78373.1; -; mRNA.
DR   RefSeq; NP_001263644.1; NM_001276715.1.
DR   AlphaFoldDB; Q9WTQ1; -.
DR   SMR; Q9WTQ1; -.
DR   BioGRID; 250093; 4.
DR   IntAct; Q9WTQ1; 1.
DR   STRING; 10116.ENSRNOP00000063159; -.
DR   iPTMnet; Q9WTQ1; -.
DR   PhosphoSitePlus; Q9WTQ1; -.
DR   PaxDb; 10116-ENSRNOP00000063159; -.
DR   Ensembl; ENSRNOT00000068077.3; ENSRNOP00000063159.2; ENSRNOG00000004165.8.
DR   Ensembl; ENSRNOT00055028072; ENSRNOP00055022587; ENSRNOG00055016533.
DR   Ensembl; ENSRNOT00060028023; ENSRNOP00060022545; ENSRNOG00060016312.
DR   GeneID; 85421; -.
DR   KEGG; rno:85421; -.
DR   UCSC; RGD:620964; rat.
DR   AGR; RGD:620964; -.
DR   CTD; 5587; -.
DR   RGD; 620964; Prkd1.
DR   eggNOG; KOG4236; Eukaryota.
DR   GeneTree; ENSGT00950000183024; -.
DR   InParanoid; Q9WTQ1; -.
DR   OMA; CHNSHRS; -.
DR   OrthoDB; 2939922at2759; -.
DR   PhylomeDB; Q9WTQ1; -.
DR   PRO; PR:Q9WTQ1; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000004165; Expressed in pancreas and 18 other cell types or tissues.
DR   ExpressionAtlas; Q9WTQ1; baseline and differential.
DR   GO; GO:0000421; C:autophagosome membrane; ISO:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0141038; F:phosphatidylinositol 3-kinase activator activity; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IDA:RGD.
DR   GO; GO:1990859; P:cellular response to endothelin; IDA:RGD.
DR   GO; GO:0071447; P:cellular response to hydroperoxide; ISO:RGD.
DR   GO; GO:0071874; P:cellular response to norepinephrine stimulus; IDA:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:1904628; P:cellular response to phorbol 13-acetate 12-myristate; IDA:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISO:RGD.
DR   GO; GO:0007030; P:Golgi organization; ISS:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IMP:RGD.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0090277; P:positive regulation of peptide hormone secretion; IMP:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IMP:RGD.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; ISO:RGD.
DR   GO; GO:0060298; P:positive regulation of sarcomere organization; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0010837; P:regulation of keratinocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0014723; P:regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril; IMP:RGD.
DR   GO; GO:0071873; P:response to norepinephrine; IDA:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   CDD; cd20839; C1_PKD1_rpt1; 1.
DR   CDD; cd20842; C1_PKD1_rpt2; 1.
DR   CDD; cd01239; PH_PKD; 1.
DR   CDD; cd14082; STKc_PKD; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR015727; Protein_Kinase_C_mu-related.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22968; PROTEIN KINASE C, MU; 1.
DR   PANTHER; PTHR22968:SF9; SERINE_THREONINE-PROTEIN KINASE D1; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000552; PKC_mu_nu_D2; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   Angiogenesis; Apoptosis; ATP-binding; Cell membrane; Cytoplasm;
KW   Differentiation; Golgi apparatus; Immunity; Inflammatory response;
KW   Innate immunity; Kinase; Magnesium; Membrane; Metal-binding; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..918
FT                   /note="Serine/threonine-protein kinase D1"
FT                   /id="PRO_0000333881"
FT   DOMAIN          428..547
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          589..845
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         144..194
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         276..326
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          338..362
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          380..408
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        712
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         595..603
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         618
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         93
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BZ03"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZL6"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         403
FT                   /note="Phosphoserine; by MAPK13"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         407
FT                   /note="Phosphoserine; by MAPK13"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         438
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         454
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         469
FT                   /note="Phosphotyrosine; by ABL"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZL6"
FT   MOD_RES         508
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K1Y2"
FT   MOD_RES         744
FT                   /note="Phosphoserine; by PKC/PRKCD"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         748
FT                   /note="Phosphoserine; by autocatalysis and PKC/PRKCD"
FT                   /evidence="ECO:0000250|UniProtKB:Q15139"
FT   MOD_RES         755
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZL6"
FT   MOD_RES         916
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15145937"
FT   CONFLICT        718
FT                   /note="V -> G (in Ref. 2; BAA78373)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   918 AA;  102043 MW;  93E46AF6C0242B86 CRC64;
     MSAPPLLRPP SPLLPAAAAV AAAAAALVPG SGPAPFPAPG AAPAGGISFH LQIGLSREPV
     LLLQDSSGDY SLAHVREMAC SIVDQKFPEC GFYGLYDKIL LFRHDPASEN ILQLVKIASD
     IQEGDLIEVV LSASATFEDF QIRPHALFVH SYRAPAFCDH CGEMLWGLVR QGLKCEGCGL
     NYHKRCAFKI PNNCSGVRRR RLSNVSLTGL GTVRTASAEF STSAPDEPLL SPVSPGFEQK
     SPSESFIGRE KRSNSQSYVG RPIQLDKLLM SKVKVPHTFV IHSYTRPTVC QFCKKLLKGL
     FRQGLQCKDC RFNCHKRCAP KVPNNCLGEV TINGELLSPG AESDVVMEEG SDDNDSERNS
     GLMDDMDEAM VQDTEMALAE GQSDGAEMQD PDADQEDSNR TISPSTSNNI PLMRVVQSVK
     HTKRRSSTVM KEGWMVHYTS KDTLRKRHYW RLDSKSITLF QNDTGSRYYK EIPLSEILCL
     EPAKPSALIP TGANPHCFEI TTANVVYYVG ENVVNPSSPP PNNSVPPSGI GTDVARMWEV
     AIQHALMPVI PKGSSVGSGT NSHKDISVSI SVSNSQIQEN VDISTVYQIF PDEVLGSGQF
     GIVYGGKHRK TGRDVAIKII DKLRFPTKQE SQLRNEVAIL QNLHHPGVVN LECMFETPER
     VFVVMEKLHG DMLEMILSSE KGRLPEHITK FLITQILVAL RHLHFKNIVH CDLKPENVLL
     ASADPFPQVK LCDFGFARII GEKSFRRSVV GTPAYLAPEV LRNKGYNRSL DMWSVGVIIY
     VSLSGTFPFN EDEDIHDQIQ NAAFMYPPNP WKEISHEAID LINNLLQVKM RKRYSVDKTL
     SHPWLQDYQT WLDLRELECR IGERYITHES DDSRWEQYAG EQGLQYPAHL INLSASHGDS
     PEAEEREMKA LSERVSIL
//
